Pancreatic biogenic amines and insulin secretion in health and disease.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism*; D002415:Cats; D006224:Cricetinae; D003533:Cyproheptadine / Q000494:pharmacology; D003920:Diabetes Mellitus / Q000378:metabolism; D004285:Dogs; D004298:Dopamine / Q000378:metabolism* / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D000882:Haplorhini; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000494:pharmacology; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects; D008784:Methysergide / Q000494:pharmacology; D051379:Mice; D009638:Norepinephrine / Q000378:metabolism* / Q000494:pharmacology; D010179:Pancreas / Q000378:metabolism*; D011817:Rabbits; D051381:Rats; D012701:Serotonin / Q000378:metabolism* / Q000494:pharmacology; D012702:Serotonin Antagonists; D014363:Tryptamines / Q000494:pharmacology
D001679:Biogenic Amines; D007328:Insulin; D012702:Serotonin Antagonists; D014363:Tryptamines; D003533:Cyproheptadine; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D006916:5-Hydroxytryptophan; D005947:Glucose; D004298:Dopamine; D009638:Norepinephrine; D008784:Methysergide